Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Effects of Purified Air Administered to the Breathing Zone in Allergic Asthma

NCT00987064 is registered in ClinicalTrials.gov with Airsonett AB as lead sponsor.

NCT NCT00987064
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00987064 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Effects of Purified Air Administered to the Breathing Zone in Allergic Asthma
Lead sponsor
Airsonett AB
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2005
Completion date
June 30, 2006
Enrollment
28 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

asthma, perennial allergy